{"id":"W3162226089","doi":"10.1038/s41467-021-22875-w","title":"Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers","year":2021,"lang":"en","type":"article","venue":"Nature Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; LUNGevity Foundation","keywords":"KRAS; MEK inhibitor; Blockade; Cancer research; Melanoma; Medicine; Lung cancer; Combination therapy; MAPK/ERK pathway; Targeted therapy; Selumetinib; Immunotherapy; Immune checkpoint; Downregulation and upregulation; PD-L1; Immune system; Biology; Kinase; Pharmacology; Immunology; Cancer; Oncology; Internal medicine; Receptor; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002184571,0.000277953,0.0002681219,0.0002623589,0.000151951,0.0004449717,0.0001555779,0.0002225441,0.001234943],"category_scores_gemma":[0.0001034789,0.0001503969,0.0002267552,0.0001018202,0.0001972804,0.0001854979,0.0002063023,0.0008372615,0.0002215264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002388842,"about_ca_system_score_gemma":0.0002575323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001835254,"about_ca_topic_score_gemma":0.000547448,"domain_scores_codex":[0.9998341,0.00003435238,0.0000108809,0.00002537647,0.00004474404,0.00005060141],"domain_scores_gemma":[0.9999123,0.0000170689,0.0000225843,0.00001126579,0.000008553717,0.00002830103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008921053,0.0003609071,0.005891406,0.0001473823,0.00004696891,0.0003540164,0.00004901673,0.0007630377,0.9558886,0.0003940068,0.0005274743,0.03468506],"study_design_scores_gemma":[0.0002128374,0.004099997,0.02653453,0.00002471536,0.0001587254,0.00281982,0.000121646,0.005958558,0.947444,0.0004333705,0.01217758,0.00001422927],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936005,0.002477904,0.001673606,0.0002222871,0.00003608418,0.00005594927,0.0001089483,0.00009301231,0.001731717],"genre_scores_gemma":[0.9973512,0.0005915915,0.000930188,0.00006587041,0.00001330617,0.00002715631,0.00005862095,0.00000830497,0.0009537865],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001234943,"threshold_uncertainty_score":0.004131317,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0132408343883211,"score_gpt":0.3061405544178952,"score_spread":0.2928997200295741,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}